InvestorsHub Logo
Followers 4
Posts 408
Boards Moderated 0
Alias Born 02/07/2007

Re: was CUIN2 post# 2914

Saturday, 07/01/2017 5:32:38 PM

Saturday, July 01, 2017 5:32:38 PM

Post# of 4159
my thanks CUIN. phew....not great news for the company... seems all earlier projections -- which didn't seem all that grandiose to begin with -- were way, way off. reasons given by company seem plausible/logical but...doesn't help much. "reluctance for users to upgrade from 1000 model" suggests that new benefits of 2000 model aren't great enough for users to make the switch... and/or that users are not happy with company's new revenue model... company clearly has some rethinking to do...

re an earlier post re company's arthritis PR of 6/29 and your reply to it: yes...theralase's PDT Cancer treatment is the big potential breakout story here, surely why most are here. But the arthritis pain/inflammation control market is itself a potential multi-billion $$ opportunity for the laser division....IF company can capitalize on it. Unclear from that PR what regulatory hoops company would have to clear to move this forward...or how company intends to address this. Would like to see more specifics re this as it seems, at least on the surface, a market for the 2000 well worth pursuing....